Last reviewed · How we verify

NCT05608811

The Effect of Social Skills Training in Visually Impaired Adolescents

Completed NA Last updated 8 November 2022
What this trial tests

NA trial testing Social Skills Training in Visual Disorder in 40 participants. Completed in 1 October 2022.

Timeline
1 July 2022
Primary endpoint
1 September 2022
1 October 2022

Quick facts

Lead sponsorSaglik Bilimleri Universitesi
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment40
Start date1 July 2022
Primary completion1 September 2022
Estimated completion1 October 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Saglik Bilimleri Universitesi — full company profile →

Who can join

Adults 13 to 19, any sex, with Visual Disorder or Young Adult. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of our study is to examine the effects of eight sessions of online social skills training given to visually impaired adolescents on social skills, self-efficacy, social phobia and social integration. Forty visually impaired adolescents between the ages of 13 and 19 participated in the study. Participants were divided into control and training groups. 20 adolescents were included in the education program. All participants included in the study were evaluated using the Sociodemographic Information Form, Social Skills Assessment Scale for Children, General Self-Efficacy Scale, Child and Adolescent Social Phobia Scale, and Social Integration Questionnaire.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Social Skills Training

Trials testing the same drug.

Other Saglik Bilimleri Universitesi trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05608811.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing